STALICLA, a Swiss clinical-stage biotech company advancing precision medicine to patients with Autism Spectrum Disorders and other Neurodevelopmental Disorders, announced today that its CEO and Founder, Lynn Durham, will present at the Swiss Biotech Day, on September 7, 2021 at the Congress Center in Basel – Switzerland.
STALICLA’s presentation will take place within the Emerging Biotech Companies Track in Therapeutics, in Singapore Room at Congress Center Basel / Messelplatz.
Tuesday September 7th, 2021 at 16:20.